New drug cocktail takes on tough pancreatic cancer
Disease control
Recruiting now
This early-stage trial tests a new drug called ProAgio combined with standard chemotherapy (gemcitabine and nab-paclitaxel) in people with advanced pancreatic cancer that has spread. Some participants also get an immunotherapy drug (atezolizumab). The main goals are to find a saf…
Phase: PHASE1 • Sponsor: ProDa BioTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC